Marc Scheineson comments on First Amendment issues surrounding the U.S. Food and Drug Administration’s crackdown on advertising by e-cigarette maker Juul.
In the News
September 10, 2019
Law360 | FDA Faces Free Speech Issues with Juul Warnings
Media Contact